|
NHEJ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.2764000000276E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34440000021385E-07 |
| Normal-vs-Stage2 |
2.636800E-01 |
| Normal-vs-Stage3 |
2.837800E-01 |
| Normal-vs-Stage4 |
6.632600E-01 |
| Stage1-vs-Stage2 |
1.438640E-01 |
| Stage1-vs-Stage3 |
3.074200E-02 |
| Stage1-vs-Stage4 |
3.510500E-02 |
| Stage2-vs-Stage3 |
8.221200E-01 |
| Stage2-vs-Stage4 |
7.251400E-01 |
| Stage3-vs-Stage4 |
8.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.04099999997942E-06 |
| Normal-vs-AfricanAmerican |
1.242230E-04 |
| Normal-vs-Asian |
4.730000E-01 |
| Caucasian-vs-AfricanAmerican |
9.275000E-01 |
| Caucasian-vs-Asian |
1.507410E-01 |
| AfricanAmerican-vs-Asian |
1.559620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34559999998007E-06 |
| Normal-vs-Female |
3.217600E-04 |
| Male-vs-Female |
6.829600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.33189999999661E-05 |
| Normal-vs-Extreme_Weight |
2.88270000092794E-08 |
| Normal-vs-Obese |
4.838900E-03 |
| Normal-vs-Extreme_Obese |
9.078600E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.468200E-01 |
| Normal_Weight-vs-Obese |
1.422170E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.960400E-01 |
| Extreme_Weight-vs-Obese |
1.941550E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.828600E-01 |
| Obese-vs-Extreme_Obese |
6.957800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.706400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.216500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.71899999579628E-08 |
| Normal-vs-Age(81-100Yrs) |
2.339100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.968330E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.032500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.847700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.399600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.297400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.649000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.73230002459479E-09 |
| Normal-VS-Type2 PRCC |
1.309220E-01 |
| Normal-VS-KIRP CIMP |
6.019200E-01 |
| Normal-VS-Unclassified PRCC |
6.758500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.299850E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.156200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.034770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.011800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.938200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.078600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.150400E-02 |
| Normal-vs-N1 |
3.764200E-01 |
| Normal-vs-N2 |
3.122200E-02 |
| N0-vs-N1 |
4.755600E-01 |
| N0-vs-N2 |
6.556000E-01 |
| N1-vs-N2 |
3.290800E-01 |
|
|
